Literature DB >> 17899192

Identification and expression analysis of novel LAGE-1 alleles with single nucleotide polymorphisms in cancer patients.

Yi Shao1, Zhen-Yuan Sun, Shi-Wei Sun, Yi Zhao, Wan Yee Sin, Yan-Hua Yuan, Andrew J Simpson, Lloyd J Old, Xin-Ting Sang, Yi-Lei Mao, Yong Xie, Jie-Fu Huang, Hai-Tao Zhao.   

Abstract

OBJECTIVE: The purpose of this study is to identify single nucleotide polymorphisms (SNPs) in the coding region alleles of the X chromosomal LAGE-1 gene, and investigate the frequency of such SNPs in both cancer patients and healthy controls, and thus determine the potential significance of these SNPs with respect to cancer vaccine therapy.
METHODS: In this study, different mRNAs transcribed from the LAGE-1 gene were identified by RT-PCR from healthy donors and cancer patients samples.
RESULTS: A new LAGE-1 allele containing three coding region SNPs (69A/G, 317C/G, and 397T/G) were identified. The allele is highly expressed as the LAGE-1a mRNA variant AY679089 in some of the cancer patients. The three SNPs altered the LAGE-1 gene sequence to that of NYESO-1 at both the nucleotide and amino acid level.
CONCLUSION: There is a high frequency of the LAGE-1 gene allele with SNPs in coding regions in cancer patients. There was a clear relationship between the variant AY679089 and gastric cancer. The SNPs may lead to accelerated progress of poorly differentiated gastric cancer. The SNPs found in these alleles may also alter the immunological characteristics of LAGE-1a and should be taken into account if this antigen is adopted as a cancer vaccine component.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899192     DOI: 10.1007/s00432-007-0312-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.

Authors:  Valérie Dutoit; Philippe Guillaume; Jean-Charles Cerottini; Pedro Romero; Danila Valmori
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

2.  A link between the p53 germ line polymorphisms and white blood cells apoptosis in lung cancer patients.

Authors:  Erik Biros; Anton Kohút; Ivan Biros; Ivan Kalina; Eva Bogyiová; Ján Stubna
Journal:  Lung Cancer       Date:  2002-03       Impact factor: 5.705

3.  Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen.

Authors:  Y Q Wei; M J Huang; L Yang; X Zhao; L Tian; Y Lu; J M Shu; C J Lu; T Niu; B Kang; Y Q Mao; F Liu; Y J Wen; S Lei; F Luo; L Q Zhou; F Peng; Y Jiang; J Y Liu; H Zhou; Q R Wang; Q M He; F Xiao; Y Y Lou; X J Xie; Q Li; Y Wu; Z Y Ding; B Hu; M Hu; W Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen.

Authors:  Hung T Khong; James C Yang; Suzanne L Topalian; Richard M Sherry; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  J Immunother       Date:  2004 Nov-Dec       Impact factor: 4.456

5.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

6.  Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses.

Authors:  Sacha Gnjatic; Djordje Atanackovic; Elke Jäger; Mitsutoshi Matsuo; Annamalai Selvakumar; Nasser K Altorki; Robert G Maki; Bo Dupont; Gerd Ritter; Yao-Tseng Chen; Alexander Knuth; Lloyd J Old
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

7.  CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients.

Authors:  Sacha Gnjatic; Elke Jäger; Weisan Chen; Nasser K Altorki; Mitsutoshi Matsuo; Sang-Yull Lee; Qiyuan Chen; Yasuhiro Nagata; Djordje Atanackovic; Yao-Tseng Chen; Gerd Ritter; Jonathan Cebon; Alexander Knuth; Lloyd J Old
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

8.  A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.

Authors:  E Stockert; E Jäger; Y T Chen; M J Scanlan; I Gout; J Karbach; M Arand; A Knuth; L J Old
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

9.  Point mutation in essential genes with loss or mutation of the second allele: relevance to the retention of tumor-specific antigens.

Authors:  G B Beck-Engeser; P A Monach; D Mumberg; F Yang; S Wanderling; K Schreiber; R Espinosa; M M Le Beau; S C Meredith; H Schreiber
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

10.  Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes.

Authors:  S Aradhya; T Bardaro; P Galgóczy; T Yamagata; T Esposito; H Patlan; A Ciccodicola; A Munnich; S Kenwrick; M Platzer; M D'Urso; D L Nelson
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

View more
  1 in total

1.  Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells.

Authors:  Jessica M Stiles; Rebecca K Rowntree; Clarissa Amaya; Dolores Diaz; Victor Kokta; Dianne C Mitchell; Brad A Bryan
Journal:  Vasc Cell       Date:  2013-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.